BioLineRx Ltd. (BLRX) stock
BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.15+0.03 (+2.68%)
Close on Nov 18, 2026Market cap $5.00MP/E –Yield –
BioLineRx shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
BioLineRx's shares outstanding was 2.66B at Jun 30, 2026. For fiscal 2025 it was 2.47B, up 105.8% from the year before. Over ten years it grew 47.3% a year on average. The highest annual figure on record is 2.47B in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.47B | +105.8% |
| FY2024 | Dec 31, 2024 | 1.20B | +24.4% |
| FY2023 | Dec 31, 2023 | 963M | +24.5% |
| FY2022 | Dec 31, 2022 | 774M | +16.7% |
| FY2021 | Dec 31, 2021 | 663M | +162.2% |
| FY2020 | Dec 31, 2020 | 253M | +72.7% |
| FY2019 | Dec 31, 2019 | 146M | +34.8% |
| FY2018 | Dec 31, 2018 | 109M | +20.7% |
| FY2017 | Dec 31, 2017 | 90M | +60.2% |
| FY2016 | Dec 31, 2016 | 56M | +9.2% |
| FY2015 | Dec 31, 2015 | 51M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 2.66B | +272.5% |
| Q2 FY2025 | Jun 30, 2025 | 2.37B | +254.1% |
| Q2 FY2024 | Jun 30, 2024 | 1.20B | +443.6% |
| Q2 FY2023 | Jun 30, 2023 | 923M | +534.5% |
| Q2 FY2022 | Jun 30, 2022 | 715M | +570.9% |
| Q2 FY2021 | Jun 30, 2021 | 669M | +608.2% |
| Q2 FY2020 | Jun 30, 2020 | 220M | – |
| Q2 FY2019 | Jun 30, 2019 | 145M | – |
| Q2 FY2018 | Jun 30, 2018 | 107M | – |
| Q2 FY2017 | Jun 30, 2017 | 94M | – |
See a number that looks wrong?